Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Pathways' Picks

CMS Prior Authorization, FDA Cybersecurity Guide, and UK Funding Guarantees

In this week’s Pathways Picks: CMS rolls out an AI-enabled prior authorization program in six states to curb “wasteful” device use, and adds reimbursement support for patients to upgrade diabetes devices; FDA publishes updated cybersecurity guide; South Korea revises its innovative device guidance; the UK plans funding guarantees for medtech; and more global policy updates.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Business Strategies

Controversy Over Chronic Low Back Pain: Will Industry Step Up?

A controversial set of papers in The British Medical Journal challenging the efficacy of common interventions for chronic low back pain reflects glaring gaps in treatment of a condition that affects millions, but industry has yet to commit substantial resources to addressing the underlying problems.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Providers & Payors

US Healthcare Spending by Condition

A comprehensive analysis of US spending on healthcare by condition aims to provide a more accurate assessment of US spending per disease, with potential to inform policy, industry, insurers, and other stakeholders. Excerpted from our recent MTS feature, Type 2 Diabetes, Dental, MSK Top US Healthcare Spending.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More